Victrex (LON:VCT) had its price objective lifted by research analysts at Berenberg Bank from GBX 1,320 ($18.24) to GBX 1,380 ($19.07) in a report released on Friday. The firm currently has a “buy” rating on the stock. Berenberg Bank’s target price points to a potential downside of 46.35% from the stock’s current price.
A number of other brokerages have also recently commented on VCT. JPMorgan Chase & Co. lifted their target price on Victrex from GBX 2,250 ($31.09) to GBX 2,580 ($35.65) and gave the stock a “neutral” rating in a report on Monday, January 8th. Deutsche Bank reiterated a “hold” rating and issued a GBX 2,200 ($30.40) target price on shares of Victrex in a report on Thursday, January 4th. Liberum Capital reiterated a “buy” rating and issued a GBX 2,770 ($38.27) target price on shares of Victrex in a report on Wednesday, January 24th. Numis Securities reiterated a “hold” rating and issued a GBX 2,550 ($35.23) target price (up previously from GBX 2,300 ($31.78)) on shares of Victrex in a report on Monday, February 12th. Finally, Barclays dropped their target price on Victrex from GBX 2,350 ($32.47) to GBX 2,270 ($31.36) and set an “equal weight” rating for the company in a report on Tuesday, November 28th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of GBX 2,246.80 ($31.04).
Victrex (VCT) opened at GBX 2,572 ($35.53) on Friday. The company has a market capitalization of $2,210.00 and a P/E ratio of 2,217.24. Victrex has a 1-year low of GBX 1,826 ($25.23) and a 1-year high of GBX 2,772 ($38.30).
TRADEMARK VIOLATION WARNING: “Victrex (VCT) Given New GBX 1,380 Price Target at Berenberg Bank” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3223646/victrex-vct-given-new-gbx-1380-price-target-at-berenberg-bank.html.
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.